Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Establishment Labs

Biotech & Life Sciences · New York City, United States · Founded 2004 · IPO 2018 Unicorn

The next generation breast aesthetics company

Valuation
$2.20B
Market cap · May/2026
Revenue
$211M
Latest reported FY
EBITDA
$15M
Latest reported FY

Investors

7 investors on Establishment Labs's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 7 investors entered at this stage
RTW Investments
Crown Predator Holdings
Kilowatt Capital
Florence Capital Advisors
JW Asset Management
Nantahala Capital Management
Madryn Asset Management

Global footprint

Where Establishment Labs has talent and traffic

Workforce by country
26 countries with
team presence
🇨🇷 Costa Rica64.8%
🇺🇸 United States12.7%
🇪🇸 Spain5%
🇧🇷 Brazil4%
🇧🇪 Belgium3.2%
Top 5 of 26 shown
Web traffic by country
4.9K monthly visits
across markets
🇺🇸 United States49%
🇨🇷 Costa Rica36.7%
🇧🇪 Belgium8.2%
🇩🇪 Germany4.1%
🇬🇧 United Kingdom2%
Top 5 markets shown

Market sentiment

What the market is saying about Establishment Labs

An AI-synthesized read of the highest-engagement posts about Establishment Labs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Establishment Labs on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.